Neumora Therapeutics
NMRA
NMRA
101 hedge funds and large institutions have $113M invested in Neumora Therapeutics in 2025 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
10% more funds holding
Funds holding: 92 → 101 (+9)
6.46% more ownership
Funds ownership: 31.3% → 37.76% (+6.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
101
Holding in Top 10
1
Calls
$1.32M
Puts
$23K
Top Buyers
| 1 | +$8.04M | |
| 2 | +$4.23M | |
| 3 | +$3.52M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.77M |
| 5 |
Two Sigma Investments
New York
|
+$2.21M |
Top Sellers
| 1 | -$3.53M | |
| 2 | -$948K | |
| 3 | -$780K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$249K |
| 5 |
SoftBank Group
Tokyo,
Japan
|
-$244K |
